In this episode of ASkinMD, Dr. Rakshitha Jayaprakash explores the treatment principles for leprosy, focusing on multidrug therapy (MDT) as outlined in Chapters 6, 7, and 8 of Jopling's Handbook and Section 6 of the IAL textbook.

Listeners will gain insights into the components of MDT—rifampicin, dapsone, and clofazimine—along with their mechanisms of action, dosing regimens, and rationale for use in both paucibacillary and lepromatous leprosy. The episode also addresses the management of leprosy reactions, specifically Type 1 and Type 2, highlighting recognition strategies and supportive measures to prevent complications. Special treatment considerations for pediatric patients, pregnant women, and individuals co-infected with HIV are also discussed.

Keywords: leprosy treatment, multidrug therapy, rifampicin, dapsone, clofazimine, leprosy reactions, pediatric leprosy, HIV co-infection, ASkinMD.

#Leprosy #TreatmentPrinciples #DermatologyEducation #MDT #MedicalPodcast #ASkinMD

Support the show

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Dr. Rakshitha Jayaprakash. Innehållet i podden är skapat av Dr. Rakshitha Jayaprakash och inte av, eller tillsammans med, Poddtoppen.

ASkinMD - Dermatology Essentials: Learn, Share, Grow

Leprosy 101: Multidrug Therapy and Patient Care | ASkinMD E10

00:00